Cargando…

A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ

BACKGROUND: Ciliated muconodular papillary tumor (CMPT) is an incredibly rare pulmonary tumor. Currently, little is known about CMPT, and it has not yet been classified by the World Health Organization. The clinical manifestation of CMPT is nonspecific and the diagnosis is only based on pathology. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lei, Willson, Conner M., Givens, Nathan T., Zhu, Ziwen, Wakefield, Mark R., Wang, Yongsheng, Yang, Wanchun, Fang, Yujiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273990/
https://www.ncbi.nlm.nih.gov/pubmed/34247594
http://dx.doi.org/10.1186/s12890-021-01581-9
_version_ 1783721480458076160
author Zhao, Lei
Willson, Conner M.
Givens, Nathan T.
Zhu, Ziwen
Wakefield, Mark R.
Wang, Yongsheng
Yang, Wanchun
Fang, Yujiang
author_facet Zhao, Lei
Willson, Conner M.
Givens, Nathan T.
Zhu, Ziwen
Wakefield, Mark R.
Wang, Yongsheng
Yang, Wanchun
Fang, Yujiang
author_sort Zhao, Lei
collection PubMed
description BACKGROUND: Ciliated muconodular papillary tumor (CMPT) is an incredibly rare pulmonary tumor. Currently, little is known about CMPT, and it has not yet been classified by the World Health Organization. The clinical manifestation of CMPT is nonspecific and the diagnosis is only based on pathology. CMPT has been documented in limited reports as a benign tumor, thus the treatment is typically with surgical excision if a solid tumor is identifiable. The prognosis of CMPT is very positive, as no recurrence has been reported in the limited literature available. However, CMPT accompanied with adenocarcinoma in situ has not been reported previously in the literature. CASE PRESENTATION: In this report, we presented a case of a 53-year-old male smoker with CMPT associated with adenocarcinoma in situ. This diagnosis was confirmed by pathological examination, including immunohistostaining. No solid resectable lesion was identified on CT scan; therefore, no surgery was performed. The patient’s adenocarcinoma in situ was disseminated in both lungs, thus chemotherapeutic treatment with cisplatin and pemetrexed was given. The patient will be continually followed up closely on a wait-and-watch basis. CONCLUSIONS: In summary, our report reveals a unique case of CMPT in conjunction with adenocarcinoma in situ, potentially revealing an association between CMPT and malignancy which has not been previously reported. More similar case studies will be beneficial to determine the authentic relationship between CMPT and adenocarcinoma in situ. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01581-9.
format Online
Article
Text
id pubmed-8273990
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82739902021-07-13 A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ Zhao, Lei Willson, Conner M. Givens, Nathan T. Zhu, Ziwen Wakefield, Mark R. Wang, Yongsheng Yang, Wanchun Fang, Yujiang BMC Pulm Med Case Report BACKGROUND: Ciliated muconodular papillary tumor (CMPT) is an incredibly rare pulmonary tumor. Currently, little is known about CMPT, and it has not yet been classified by the World Health Organization. The clinical manifestation of CMPT is nonspecific and the diagnosis is only based on pathology. CMPT has been documented in limited reports as a benign tumor, thus the treatment is typically with surgical excision if a solid tumor is identifiable. The prognosis of CMPT is very positive, as no recurrence has been reported in the limited literature available. However, CMPT accompanied with adenocarcinoma in situ has not been reported previously in the literature. CASE PRESENTATION: In this report, we presented a case of a 53-year-old male smoker with CMPT associated with adenocarcinoma in situ. This diagnosis was confirmed by pathological examination, including immunohistostaining. No solid resectable lesion was identified on CT scan; therefore, no surgery was performed. The patient’s adenocarcinoma in situ was disseminated in both lungs, thus chemotherapeutic treatment with cisplatin and pemetrexed was given. The patient will be continually followed up closely on a wait-and-watch basis. CONCLUSIONS: In summary, our report reveals a unique case of CMPT in conjunction with adenocarcinoma in situ, potentially revealing an association between CMPT and malignancy which has not been previously reported. More similar case studies will be beneficial to determine the authentic relationship between CMPT and adenocarcinoma in situ. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-021-01581-9. BioMed Central 2021-07-12 /pmc/articles/PMC8273990/ /pubmed/34247594 http://dx.doi.org/10.1186/s12890-021-01581-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Zhao, Lei
Willson, Conner M.
Givens, Nathan T.
Zhu, Ziwen
Wakefield, Mark R.
Wang, Yongsheng
Yang, Wanchun
Fang, Yujiang
A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ
title A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ
title_full A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ
title_fullStr A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ
title_full_unstemmed A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ
title_short A rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ
title_sort rare case of ciliated muconodular papillary tumor accompanied with adenocarcinoma in situ
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273990/
https://www.ncbi.nlm.nih.gov/pubmed/34247594
http://dx.doi.org/10.1186/s12890-021-01581-9
work_keys_str_mv AT zhaolei ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT willsonconnerm ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT givensnathant ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT zhuziwen ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT wakefieldmarkr ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT wangyongsheng ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT yangwanchun ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT fangyujiang ararecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT zhaolei rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT willsonconnerm rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT givensnathant rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT zhuziwen rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT wakefieldmarkr rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT wangyongsheng rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT yangwanchun rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu
AT fangyujiang rarecaseofciliatedmuconodularpapillarytumoraccompaniedwithadenocarcinomainsitu